145 research outputs found
A Case of Catecholaminergic Polymorphic Ventricular Tachycardia
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a familial cardiac arrhythmia that is related to RYR2 or CASQ2 gene mutation. It occurs in patients with structurally normal heart and causes exercise-emotion-triggered syncope and sudden cardiac death. We experienced a case of CPVT in an 11 year-old female patient who was admitted for sudden cardiovascular collapse. The initial electrocardiogram (ECG) on emergency department revealed ventricular fibrillation. After multiple defibrillations, sinus rhythm was restored. However, recurrent ventricular fibrillation occurred during insertion of nasogastric tube without sedation in coronary care unit. On ECG monitoring, bidirectional ventricular tachycardia occurred with sinus tachycardia and then degenerated into ventricular fibrillation. To our knowledge, there has been no previous case report of CPVT triggered by sinus tachycardia in Korea. Therefore, we report the case as well as a review of the literature
Histopathological retrospective study of canine renal disease in Korea, 2003~2008
Renal disease includes conditions affecting the glomeruli, tubules, interstitium, pelvis, and vasculature. Diseases of the kidney include glomerular diseases, diseases of the tubules and interstitium, diseases of renal pelvis, and developmental abnormalities. Renal tissue samples (n = 70) submitted to the Department of Veterinary Pathology of Konkuk University from 2003 to 2008 were included in this study. Tissue histopathology was performed using light microscopy with hematoxylin and eosin stains. Masson's trichrome, Congo Red, and Warthin starry silver staining were applied in several individual cases. Glomerular diseases (22.9%), tubulointerstitial diseases (8.6%), neoplastic diseases (8.6%), conditions secondary to urinary obstruction (24.3%), and other diseases (35.7%) were identified. Glomerulonephritis (GN) cases were classified as acute proliferative GN (5.7%), membranous GN (4.3%), membranoproliferative GN (4.3%), focal segmental GN (2.9%), and other GN (4.2%). The proportion of canine GN cases presently identified was not as high as the proportions identified in human studies. Conversely, urinary obstruction and end-stage renal disease cases were relatively higher in dogs than in human populations
Pro- and anti-inflammatory cytokine expression and histopathological characteristics in canine brain with traumatic brain injury
We analyzed the expression level and cellular localization of pro- and anti-inflammatory cytokines and histopathologically characterized canine traumatic brain injury (TBI). Canine TBI brains revealed subarachnoid and cerebral cortical hemorrhage, neutrophilic infiltration, neuronal necrosis, astrocytosis, and vasogenic edema. Immunohistochemical evaluations suggested that both pro-inflammatory cytokines [interleukin (IL)-1Ξ², IL-6, and tumor necrosis factor-Ξ±] and anti-inflammatory cytokines [IL-10 and transforming growth factor-beta (TGF-Ξ²)] were highly expressed in neurons and neutrophils. In particular, the highest magnitude of expression was identified for IL-1Ξ² and TGF-Ξ². This data helps describe the pathologic characteristics of canine TBI, and may help in the design of potential therapeutic approaches to control secondary damage by inflammatory cytokines
Screening of the A11084G Polymorphism and Scanning of a Mitochondrial Genome SNP in Korean Migraineurs
Integrated Expression Profiling and Genome-Wide Analysis of ChREBP Targets Reveals the Dual Role for ChREBP in Glucose-Regulated Gene Expression
The carbohydrate response element binding protein (ChREBP), a basic helix-loop-helix/leucine zipper transcription factor, plays a critical role in the control of lipogenesis in the liver. To identify the direct targets of ChREBP on a genome-wide scale and provide more insight into the mechanism by which ChREBP regulates glucose-responsive gene expression, we performed chromatin immunoprecipitation-sequencing and gene expression analysis. We identified 1153 ChREBP binding sites and 783 target genes using the chromatin from HepG2, a human hepatocellular carcinoma cell line. A motif search revealed a refined consensus sequence (CABGTG-nnCnG-nGnSTG) to better represent critical elements of a functional ChREBP binding sequence. Gene ontology analysis shows that ChREBP target genes are particularly associated with lipid, fatty acid and steroid metabolism. In addition, other functional gene clusters related to transport, development and cell motility are significantly enriched. Gene set enrichment analysis reveals that ChREBP target genes are highly correlated with genes regulated by high glucose, providing a functional relevance to the genome-wide binding study. Furthermore, we have demonstrated that ChREBP may function as a transcriptional repressor as well as an activator
Characterization of phenotypic variants of Clavibacter michiganensis subsp. michiganensis isolated from Capsicum annuum
Recommended from our members
Prevalence and detection of low-allele-fraction variants in clinical cancer samples
Accurate detection of genomic alterations using high-throughput sequencing is an essential component of precision cancer medicine. We characterize the variant allele fractions (VAFs) of somatic single nucleotide variants and indels across 5095 clinical samples profiled using a custom panel, CancerSCAN. Our results demonstrate that a significant fraction of clinically actionable variants have low VAFs, often due to low tumor purity and treatment-induced mutations. The percentages of mutations under 5% VAF across hotspots in EGFR, KRAS, PIK3CA, and BRAF are 16%, 11%, 12%, and 10%, respectively, with 24% for EGFR T790M and 17% for PIK3CA E545. For clinical relevance, we describe two patients for whom targeted therapy achieved remission despite low VAF mutations. We also characterize the read depths necessary to achieve sensitivity and specificity comparable to current laboratory assays. These results show that capturing low VAF mutations at hotspots by sufficient sequencing coverage and carefully tuned algorithms is imperative for a clinical assay
GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression
GPR55 recognizes several lipid molecules such as lysophosphatidylinositol. GPR55 expression was reported in human monocytes. However, its role in monocyte adhesion and atherosclerosis development has not been studied. The role of GPR55 in monocyte adhesion and atherosclerosis development was investigated in human THP-1 monocytes and ApoE−/− mice using O-1602 (a potent agonist of GPR55) and CID16020046 (a specific GPR55 antagonist). O-1602 treatment significantly increased monocyte adhesion to human umbilical vein endothelial cells, and the O-1602-induced adhesion was inhibited by treatment with CID16020046. O-1602 induced the expression of Mac-1 adhesion molecules, whereas CID16020046 inhibited this induction. Analysis of the promoter region of Mac-1 elucidated the binding sites of AP-1 and NF-κB between nucleotides −750 and −503 as GPR55 responsive elements. O-1602 induction of Mac-1 was found to be dependent on the signaling components of GPR55, that is, Gq protein, Ca2+, CaMKK, and PI3K. In Apo−/− mice, administration of CID16020046 ameliorated high-fat diet-induced atherosclerosis development. These results suggest that high-fat diet-induced GPR55 activation leads to the adhesion of monocytes to endothelial cells via induction of Mac-1, and CID16020046 blockage of GPR55 could suppress monocyte adhesion to vascular endothelial cells through suppression of Mac-1 expression, leading to protection against the development of atherosclerosis
AR6 SSP-RCP μλλ¦¬μ€ κΈ°λ° λμμμ μ΄μ€νΈλ μ€ λ°μνΉμ±μ λ―Έλμ λ§
κΈ°νλ³ν μν₯νκ° λ° λμλμ±
μ μ§μμ μν΄μλ λ€μν λΆλ¬Έμ λν μμΈ κΈ°νλ³ν μν₯μ 보μ λΆμ λ° νκ°κ° νμνλ€. μ΅κ·Ό μ¬λ¦μ² νμΌμ λΉλ²ν μΆνκ³Ό κ°λμ κ°νλ‘ μ΄ κ΄λ ¨ μ§λ³κ³Ό μ¬λ§λ₯ μ΄ λμμ§μ λ°λΌ, μ΄μ€νΈλ μ€μ κ°μ΄ 보건λΆλ¬Έμμ νμ© κ°λ₯ν μμ©μ 보μ νμμ±μ΄ μ¦κ°νκ³ μλ€. λ³Έ μ°κ΅¬μμλ μ΄μ€νΈλ μ€μ λνμ§μμΈ WBGT(wet bulb globe temperature)λ₯Ό μ΄μ©νμ¬ λ―Έλμ λμμμ μ΄μ€νΈλ μ€ λ°μνΉμ±μ μ λ§νμλ€. μ΄λ₯Ό μν΄ νΈμ보μ λ CORDEX λμμμ μ§μκΈ°νλͺ¨λΈ(HadGEM-RA, CCLM, WRF, RegCM, GRIMs) λͺ¨μμλ£λ₯Ό 4μ’
μ SSP(SSP1-2.6, 2-4.5, 3-7.0, 5-8.5) μλ리μ€μ λνμ¬ λΆμνμλ€. 21μΈκΈ° νλ°κΈ°(2081-2100λ
)μ λμμμ μ¬λ¦μ² νκ· μ΄μ€νΈλ μ€λ νμ¬(1979-2014λ
) λλΉ +3.1 (SSP1-2.6)μμ +7.5 (SSP5-8.5)κΉμ§ μμΉνμλ€. κΈ°μ¨κ³Ό μλμ΅λμ ν¨μλ‘ μ°μΆλλ μ΄μ€νΈλ μ€μ λ³νλ λλΆλΆμ΄ κΈ°μ¨μ μν΄ μ€λͺ
λμ§λ§, μ§μκ³Ό μλ리μ€μ λ°λΌ μλμ΅λμ λ³νκ° μ΄μ€νΈλ μ€λ₯Ό κ°ν λλ μνμν€λ κ²μΌλ‘ λνλ¬λ€. 21μΈκΈ° νλ°κΈ°μ μ€κ΅ λΆλΆμμλ μ¬λ¦μ² νκ· μλμ΅λκ° μ¦κ°νλ©΄μ μ΄μ€νΈλ μ€κ° κ°νλκ³ , μμ―κ°μ μκ³Ό μΌλ³Έμμλ μλμ΅λκ° κ°μνλ©΄μ μ΄μ€νΈλ μ€μ μ¦κ°κ° μνλ κ²μΌλ‘ μ λ§λμλ€. μ¬λ¦μ² κ·Ήν μ΄μ€νΈλ μ€(맀λ
μμ 5%) λ°μ μμλ νκ· μν λ³΄λ€ μλμ΅λμ κΈ°μ¬λκ° λ ν¬κ² μ¦κ°νμμΌλ©°, κ³ λ°°μΆ μλ리μ€μ λΉν΄ μ λ°°μΆ μλ리μ€μμ κ·Έ μν₯μ΄ λ λλ ·νμλ€.
λμμμλ₯Ό 6κ° μΈλΆμμ(μ€κ΅ λΆλΆ, λΆλλΆ, λ¨λΆ, μμ―κ°μ μ, νλ°λ, μΌλ³Έ)μΌλ‘ ꡬλΆνμ¬ μμλ³ κ·Ήν μ΄μ€νΈλ μ€μΌμ λΆμν κ²°κ³Ό, κ³ λ°°μΆ μλ리μ€μμ λͺ¨λ μμμ κ·Ήν μ΄μ€νΈλ μ€μΌμ 21μΈκΈ° νλ°κΈ°μ νμ¬λ³΄λ€ 10λ°° λΉλ²νκ² λ°μνλ©°, κ°λκ° κ°ν΄μ§κ³ λ°μλ©΄μ λν λμ΄μ Έ μ΄μ€νΈλ μ€μ μν₯μ΄ ν¬κ² μ¦κ°ν κ²μΌλ‘ μ λ§λμλ€. κ·Ήν μ΄μ€νΈλ μ€μΌμ λ°μ μμμΌμ μλΉκ²¨μ§κ³ , μ’
λ£μΌμ λ¦μ΄μ§ κ²μΌλ‘ μ λ§λλ©°, κ³ λ°°μΆ μλ리μ€μΌμλ‘ λ°μκΈ°κ°μ΄ ν¬κ² νμ₯λ κ²μΌλ‘ μ λ§λμλ€. νμ¬ κ° μΈλΆμμμμ νκ· 5 6μΌ μ λ μ§μλμ΄ λ°μνλ κ·Ήν μ΄μ€νΈλ μ€μΌμ΄ κ³ λ°°μΆ μλ리μ€μμλ 21μΈκΈ° νλ°κΈ°μ νκ· 80μΌ μ΄μ μ§μλμ΄ μ¬λ¦μ² λλΆλΆμ κΈ°κ°μ κ·Ήννμμ΄ μ§μμ μΌλ‘ λ°μν κ²μΌλ‘ μ λ§λμλ€.2
- β¦